April 5, 2010 Cover, Vol. 88, Issue 14
Treating Alzheimer's
Late-stage clinical trials will soon tell whether blocking amyloid-β can slow the disease. (pp. 12-17)
The Amyloid Question pp. 12-17
Alzheimer's researchers will soon know whether blocking amyloid-β can slow down the debilitating disease.
'Beta Testing' p. 14
ACS Meeting News: Using chemistry tools to refine an Alzheimer's drug candidate.
The Dimebon Debacle Web Exclusive
Medivation and Pfizer salvage what they can from the failure of a large Phase III trial for a promising Alzheimer's drug.
COVER: The brains of people with Alzheimer's disease are riddled with amyloid plaques (in orange) that clog the spaces between nerve cells. Elan Pharmaceuticals
Copyright © 2010 American Chemical Society
Services & Tools
ACS Resources
ACS Careers
ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers
» Join ACS
Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!